Aida uses machine learning and gene expression of individual tumors to help clinicians to prescribe the best drugs for each cancer patient.
Aida Oncology has raised $533K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2023.
Aida Oncology's investors include BioInnovation Institute Venture Lab.
Aida Oncology is headquartered in Copenhagen, Denmark.
Aida uses machine learning and gene expression of individual tumors to help clinicians to prescribe the best drugs for each cancer patient.
Aida Oncology is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aida Oncology — Funding & Investors." VCBacked, March 1, 2023, https://www.vcbacked.co/company/aida-oncology. Accessed August 15, 2026.
VCBacked. (2023). Aida Oncology — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/aida-oncology
{{cite web |title=Aida Oncology — Funding & Investors |url=https://www.vcbacked.co/company/aida-oncology |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated